Mark Rubinstein, Medical University of South Carolina (IMAGE)
Caption
Cancer immunologist Mark Rubinstein (above right) helped design the clinical trial that will test whether a two-drug combination can boost some lung cancer patients' immune response to the disease.
Credit
Brennan Wesley
Usage Restrictions
None
License
Licensed content